Gill, P. S. and Grewal, N. (2017) “Mirabegron: first β3 agonist in treatment of overactive bladder”, International Journal of Basic & Clinical Pharmacology, 1(2), pp. 120–121. Available at: https://www.ijbcp.com/index.php/ijbcp/article/view/1410 (Accessed: 16 April 2026).